A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH)

NCT06643143 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study has undergone sponsorship and design changes.

Conditions

Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

Interventions

DRUG: IkT-001Pro
DRUG: Placebo

Sponsor

Inhibikase Therapeutics